Patient randomization is nearly complete in Medicinova’s Phase 2b/3 COMBAT-ALS trial testing MN-166 (ibudilast) for the ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...

Throughout my years of testing robot vacuums in my own various apartments, I've developed a pretty solid strategy for ...

Northrop Grumman has successfully ground tested the motor that could be used for the historic first orbital rocket launch from another planet. The solid rocket booster is intended to help return the ...

Parallel to the dynamic exhibition floor, Frigair also boasted an exceptional series of 17 free-to-attend workshops ...

For the first time, Frigair 2025 proudly hosted a Skills Development Hub, a pioneering initiative that thoroughly tested six young talents in critical areas: electrical/3-phase motor testing and ...

For decades, the narrative around Parkinson’s disease treatment has focused primarily on dopamine replacement. The loss of ...

The SINAMICS S210 next generation servo-drive system is ready for digitalization and brings an enhanced level of safety and ...

Biohaven’s valuation has dropped from $3.9B to $1.42B, but no revenue and high cash burn still limit its appeal. Read why ...

Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.

Q2 2025 Earnings Call Transcript July 24, 2025 RPC, Inc. misses on earnings expectations. Reported EPS is $0.04652 EPS, ...